The (re)challenging question of erythropoiesis-stimulating agents inducing pure red cell aplasia.
Shaun
S
Summers
Stephen
S
Holdsworth
Edward
E
Sharples
D000740:Anemia / Q000188:drug therapy / Q000209:etiology; D000917:Antibody Formation; D004921:Erythropoietin / Q000008:administration & dosage / Q000009:adverse effects* / Q000276:immunology; D006397:Hematinics / Q000008:administration & dosage / Q000009:adverse effects* / Q000276:immunology; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007676:Kidney Failure, Chronic / Q000150:complications / Q000188:drug therapy; D011994:Recombinant Proteins; D012010:Red-Cell Aplasia, Pure / Q000209:etiology* / Q000276:immunology / Q000628:therapy
D006397:Hematinics; D007166:Immunosuppressive Agents; D011994:Recombinant Proteins; D004921:Erythropoietin